KRMD (KORU Medical Systems) Net Profit

Official company branding of korumedical.com (KRMD)

KORU Medical Systems (KRMD) relies on a niche segment of home drug delivery systems, supported by the global medical shift toward outpatient care. High barriers to entry are ensured by pump patents and strict FDA oversight, which guarantees dosing accuracy. The current profit figure stands at -0.00, and the price trend on the GURU.Markets platform clearly demonstrates the financial dynamics of this medtech manufacturer.

KRMD: KORU Medical Systems Inc. Net Income 07/04/2022 - 10/30/2026

Analytical breakdowns and data insights for company korumedical.com (KRMD)

- price and consensus price forecast:
Stock Quotes KORU Medical|KRMD - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization KORU Medical Systems|KRMD - Total Company Value
- book capitalization data:
Net Assets per Single Share KORU Medical Systems|KRMD - Company Net Assets|Market Value to Book Value korumedical.com|KRMD - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient KORU Medical Systems|KRMD - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio KORU Medical|KRMD - Company Debts|Debts to Net Assets KORU Medical Systems|KRMD - Company Long-Term Liabilities|Amount of Current Liabilities KORU Medical Systems|Intermediate Coverage Ratio korumedical.com
- earnings and valuation multiples information:
KRMD - Net Income
Basic company analysis:KRMD - KORU Medical Systems Inc.
Mass-produced product of KORU Medical Systems Inc.

KORU Medical Systems occupies a strategic niche within the high-tech medical equipment sector. The company's operating profit dynamics reflect the efficiency of its premium consumables monetization and the issuer's strong pricing power. This indicator measures the final financial result, aggregating all market changes in real-time. Sharp fluctuations in the curve signal the business's sensitivity to market conditions. Steady growth of this metric confirms the resilience of a model characterized by low demand elasticity.

Key competitors

Net Income Intuitive Corp|DHR (Danaher Corp.) - Net Profit|Net Profit bd.com|Company Net Income STERIS (STE)|Company Net Income WST (West Pharma)|Baxter Corp - Net Income|Final Profit MASI|Stevanato Group S.p.A. - Net Profit|Net Financial Result teleflex.com TFX|Merit Medical (MMSI) - Company Net Income|Company Profit NVST|Company Net Income ICU Medical Corp|Sirona Dental Systems (XRAY) - Net Financial Result|Net Income LMAT (LeMaitre Vascular, Inc.)|Profit After Payment of Taxes ATRC|Company Net Income STAAR Surgical STAA|Final Profit NAGE|ZIMV: Net Income|ANGO - Net Profit|Cerus Corporation (CERS) - Company Net Income|Net Income teknova.com|MGRM (Monogram Orthopedics) - Net Profit|Company Net Income Sharps Tech STSS|Company Net Income InfuSystem Holdings (INFU)|Utah Med - Company Profit|Nyxoah S.A. - Net Income|Profit After Payment of Taxes MBOT (microbotmedical.com)|PDEX - Company Net Income|Net Financial Result Zentek Ltd ZTEK|Elutia Corp (ELUT) - Company Net Income|Milestone Scientific Corporation (MLSS) - Net Profit|Company Net Income NEXGEL, Inc.|Company Net Income Retractable Tech RVP|Company Net Income Harvard Bioscience, Inc. (HBIO)|FEMY (Femasys Inc) - Final Profit|Meihua Medical Technologies Co., Ltd. - Net Income|Net Profit Predictive Oncology Inc POAI|CJMB: Net Income|Final Profit ATRI (atrioncorp.com)|NeuroMetrix (NURO) - Company Net Income